Select Drug Profiles

Select Drug Profiles, Payers' Guide
Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer When Curative Surgery or Radiation Therapy Is Not an Option
Lynne Lederman, PhD
Read More
Select Drug Profiles, Payers' Guide
Eliquis Approved by the FDA to Reduce the Risks of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
Loretta Fala
Read More
Select Drug Profiles, Payers' Guide
The Health Burden of Multiple Myeloma: Subcutaneous Velcade a New, Convenient Route of Administration Option
Rhonda Williams, Medical Writer
Read More
Select Drug Profiles, Payers' Guide
Kyprolis: A New Treatment Option for Patients with Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib and an Immunomodulatory Agent
Lynne Lederman, PhD, Medical Writer
Read More
Select Drug Profiles, Payers' Guide
Jentadueto: A New Oral Antihyperglycemic Combination Therapy for Patients with Type 2 Diabetes
Wayne Kuznar, Medical Writer
Read More
Select Drug Profiles, Payers' Guide
Linzess: A Novel Treatment Option for Constipation Associated with Irritable Bowel Syndrome
Alice Goodman, Medical Writer
Read More
Select Drug Profiles, Payers' Guide
Perjeta: A New Option for Patients with HER2-Positive Metastatic Breast Cancer
Alice Goodman, Medical Writer
Read More
Select Drug Profiles, Payers' Guide
Iclusig: A New Treatment Option for Adults with CML or Ph+ ALL that Is Resistant/ Intolerant to Previous Therapy with TKIs
Lynne Lederman, PhD, Medical Writer
Read More
Select Drug Profiles, Payers' Guide
Qsymia: Combination Oral Therapy a New Weight-Loss Option for Obese or Overweight Patients
Loretta Fala
Read More
Select Drug Profiles, Payers' Guide
Rayos: A Novel Oral Delayed-Release Prednisone for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases
Alice Goodman, Medical Writer
Read More
Page 1 of 20
Results 1 - 10 of 200
SUBSCRIBE
Copyright © Amplity Medical Communications. All rights reserved.